FDA Greenlights First Motion Sickness Drug in More Than 40 Years

(MedPage Today) — The FDA approved tradipitant (Nereus), an oral neurokinin-1 (NK-1) receptor antagonist, to prevent vomiting induced by motion in adults, Vanda Pharmaceuticals announced Tuesday.
The approval marks the first new drug treatment…

Source link : https://www.medpagetoday.com/neurology/generalneurology/119230

Author :

Publish date : 2025-12-31 14:16:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

FDA Greenlights First Motion Sickness Drug in More Than 40 Years

SNAP Bans on Soda, Candy, and Other Foods Take Effect in Five States Jan. 1

Chevy Chase’s Memory Loss; New Variant Fuels Flu Cases; Ivermectin on the Rise

Related Posts

‘Z-Drug’ Use in Early Pregnancy: New Safety Data

Race for the Rheum Disease Cure Heats Up

Chevy Chase’s Memory Loss; New Variant Fuels Flu Cases; Ivermectin on the Rise

SNAP Bans on Soda, Candy, and Other Foods Take Effect in Five States Jan. 1

Turning Point for Hunter Syndrome?

Genetic Variants May Thwart Monoclonal Antibody Binding

‘Z-Drug’ Use in Early Pregnancy: New Safety Data

Race for the Rheum Disease Cure Heats Up

Chevy Chase’s Memory Loss; New Variant Fuels Flu Cases; Ivermectin on the Rise

FDA Greenlights First Motion Sickness Drug in More Than 40 Years

SNAP Bans on Soda, Candy, and Other Foods Take Effect in Five States Jan. 1

Turning Point for Hunter Syndrome?

Genetic Variants May Thwart Monoclonal Antibody Binding

Tackling Inequity in Respiratory Medicine

Categories

Archives